Neptune Wellness Solutions Inc. - CEO, Michael Cammarata
CEO, Michael Cammarata
Source: Forbes
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Neptune Wellness Solutions (TSX:NEPT) has appointed Dr. Toni Rinow as the company’s new CFO
  • Toni has held a variety of leadership roles in both private and public healthcare companies
  • She also holds a double Masters in Business Administration (MBA) and Accounting and Finance from McGill University
  • Toni currently sits on the Board of Directors of several not-for-profit organisations
  • Neptune Wellness Solutions (NEPT) is currently up 0.62 per cent to C$1.62 per share, with a market cap of $153.83 million

Healthcare provider, Neptune Wellness Solutions (TSX:NEPT), has appointed Dr. Toni Rinow as the company’s new CFO.

With over 100 customers in a variety of industries, the company specialises in the extraction, purification and formulation of health and wellness products.

Toni has more than 20 years of experience in finance and business leadership. She has a proven track record in accelerating revenue streams via acquisitions, corporate development, sales and marketing, and financing.

Having trained at the Massachusetts Institute of Technology (MIT), Toni also has a keen interest in robotics, natural language processing and machine learning, with a particular focus on retail consumer markets.

Toni said she is excited to be rejoining the Neptune Wellness team at a pivotal point in the company’s history and growth trajectory.

“I am looking forward to putting the knowledge I’ve learned over the last decade to good use to help guide Neptune through its next inflection points while positioning the company for future growth,” she added.

Toni holds a double Masters degree in Business Administration (MBA) and Accounting and Finance from McGill University. In addition, she obtained a doctorate in physical chemistry from the Université de Montréal and a chemical engineering degree from the European Higher Institute of Chemistry in Strasbourg, France.

Michael Cammarata, CEO of Neptune Wellness Solutions, noted Toni’s diverse expertise and significant executive business, financial and technical leadership.

“Toni is an extremely accomplished and adaptable problem solver with international experience growing businesses, executing transformational plans, and building high performance teams.

“Her experience with private equity sponsors has allowed her to take on diverse leadership roles across industries, applying each of her broad capabilities from executive leadership, maximizing operational and production effectiveness, and applying strong business controls,” he said.

Neptune Wellness Solutions (NEPT) is currently up 0.62 per cent to C$1.62 per share at 12:08pm EST.

More From The Market Herald

" Revive Therapeutics (CSE:RVV) updates Bucillamine in treating COVID-19

Revive Therapeutics (RVV) announced an update of its Food and Drug Administration (FDA) phase three clinical trial for Bucillamine.
The Market Herald Video

" BioVaxys (CSE:BIOV) signs binding term sheet for distribution of Papilocare in the U.S.

BioVaxys Technology Corp. (BIOV) has signed a binding term sheet with Procare Health Iberia, S.L. of Barcelona, Spain.

" Satellos Bioscience (TSXV:MSCL) announces OTCQB listing

Common shares of Satellos Bioscience (MSCL) have commenced trading on the OTCQB Venture Market (OTCQB) under the symbol MSCLF.
Innocan Pharma - CEO Iris Bincovish

" Innocan Pharma (CSE:INNO) patent application for treatment of psoriasis of the scalp goes national

Innocan Pharma’s (INNO) patent application, which claims cannabinoid-based topical compositions can treat psoriasis of the scalp, has reached the national phase.